Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy

December 29, 2017 updated by: Beijing Pins Medical Co., Ltd

Vagus Nerve Stimulation for Pediatric Intractable Epilepsy (VNS-PIE)

Children with refractory epilepsy who are candidates for a treatment with vagus nerve stimulation will be prospectively randomized into 2 arms. Vagus nerve stimulation parameters are programmed and adjusted during outpatient clinic visits, within the normal clinical practice.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Recruiting
        • Peking University First Hospital
        • Contact:
          • Yuwu Jiang
          • Phone Number: 010-83573228

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 3-6
  2. At least 6 seizure per month
  3. Refractory Epilepsy
  4. In good health except epilepsy
  5. Patients or his(her) familyscould understand this method and sign the informed consent
  6. Patients with good compliance and could complete postoperative follow-up

Exclusion Criteria:

  1. Results of MRI remind epilepsy caused by intracranial space-occupying lesions
  2. The vagus nerve lesion and damage
  3. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma,mental disease,pepticulcer,diabetes,bad health etc, and other surgical contraindication
  4. Cann't write the epilepsy diary
  5. Participating other clinical trial
  6. Cann't complate the operation
  7. Complete the postoperative follow-up
  8. Cann't complete the promgramming

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Subjects'Vagus Nerve stimulator is on always
PINS Vagus Nerve Stimualtor
Sham Comparator: Control
Subjects'Vagus Nerve stimulator is off from enrollment to 3 month
PINS Vagus Nerve Stimualtor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in seizure frequency
Time Frame: 12 weeks of stimulation
12 weeks of stimulation

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes in seizure frequency
Time Frame: 6、12、24 weeks of stimulation
6、12、24 weeks of stimulation
Engel scale description
Time Frame: 6、12、24 weeks of stimulation
6、12、24 weeks of stimulation
Changes in the Number of Anti-epileptic Drugs
Time Frame: 6、12、24 weeks of stimulation
6、12、24 weeks of stimulation
GESELL mental development scales
Time Frame: 12、24 weeks of stimulation
12、24 weeks of stimulation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuwu Jiang, MD, Peking University First Hospital
  • Study Director: Liping Zou, Chinese PLA General Hospital
  • Study Director: Jianxiang Liao, Shenzhen Children's Hospital
  • Study Director: Qian Chen, Children's Hospital of The Capital Institute of Pediatrics
  • Study Director: Baomin Li, Qilu Hospital of Shandong University
  • Study Director: Yuxing Gao, Shandong Provincial Hospital
  • Study Director: Jianmin Liang, The First Hospital of Jilin University
  • Study Director: Shaoping Huang, Second Affiliated Hospital of Xi'an JiaoTong University
  • Study Director: Fei Yin, Xiangya Hospital of Central South University
  • Study Director: Feng Gao, The Children's Hospital of Zhejiang University School of Medicine
  • Study Director: Yanhui Chen, Fujian Medical University Union Hospital
  • Study Director: XiaoMei SHU, Zunyi Medical College
  • Study Director: Hua Yu, Shengjing Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2017

Primary Completion (Anticipated)

July 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

February 15, 2017

First Submitted That Met QC Criteria

February 20, 2017

First Posted (Actual)

February 23, 2017

Study Record Updates

Last Update Posted (Actual)

January 2, 2018

Last Update Submitted That Met QC Criteria

December 29, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PINS-026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractory Epilepsy

Clinical Trials on PINS Vagus Nerve Stimualtor

Subscribe